Project using stem cell-derived tissues to rapidly test drugs already approved for use in humans for activity against COVID-19.
- Funded by Medical Research Future Fund (MRFF)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$1,913,724.87Funder
Medical Research Future Fund (MRFF)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
Peter Doherty Institute for Infection and Immunity; Queensland Institute of Medical Research BerghoferResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementation
Research Subcategory
Prophylactic use of treatments
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Project using stem cell-derived tissues to rapidly test drugs already approved for use in humans for activity against COVID-19.